Direkt zum Inhalt
Merck
  • What we have learned about bumetanide and the concept of multispecific bile acid/drug transporters from the liver.

What we have learned about bumetanide and the concept of multispecific bile acid/drug transporters from the liver.

Journal of hepatology (1996-01-01)
E Petzinger, M Blumrich, B Brühl, U Eckhardt, W Föllmann, W Honscha, J A Horz, N Müller, L Nickau, M Ottallah-Kolac, H D Platte, A Schenk, K Schuh, K Schulz, S Schulz
ZUSAMMENFASSUNG

Bumetanide is a weak organic acid which is transported into hepatocytes by a transport system that is related neither to the cloned sodium-dependent taurocholate cotransporting polypeptide Ntcp nor to the cloned organic anion transporting polypeptide oatp. Bumetanide is known to be transported in the kidney by a multispecific organic anion transporter which is the pAH-transporter from the proximal tubule cell. In the liver, bumetanide uptake competes with bile acid uptake, indicating a functionally related multispecific transporter for bile acids and drugs in hepatocytes. This multispecific bile acid transporter MBAT has not been cloned yet. When basolateral membranes were photoaffinity labeled with [3H]bumetanide, several bumetanide binding proteins were separated and identified after protein sequencing from two-dimensional electrophoresis gels.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Bumetanid, ≥98%
Bumetanid, European Pharmacopoeia (EP) Reference Standard